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Abstract
Introduction. The steady increase of dogs with diagnosed testicular neoplasms observed in recent years prompted 
us to carry out immunohistochemical (IHC) studies for their better characterization. The aim of the study was to 
analyze most common canine testicular neoplasms (seminomas, Leydig cell and Sertoli cell tumors) with selected 
IHC markers and to compare the expressions of these proteins in corresponding canine and human testicular tumors. 
Material and methods. Studies were carried out on testicular canine tumors: 40 cases of seminoma, 40 cases of 
Leydig cell tumor and 40 cases of Sertoli cell tumor. Moreover, 15 cases of human seminomas and 5 cases of 
human Leydig cell tumors were also analyzed. Immunohistochemistry was performed on paraffin sections by 
standard technique using monoclonal anti-human antibodies against E-cadherin, inhibin-a, calretinin and Ki-67. 
The slides were subjected to computer-aided image analysis and the intensity of the immunoreactivity was 
assessed by a semi-quantitative scoring system. 
Results. Due to the very low prevalence of the Sertoli cell-derived tumors in the human population, we were 
able to examine the markers’ expression only in the canine gonadal tumors. We revealed that, apart from 
E-cadherin in Leydig cell tumors and calretinin in seminomas, the expression of all the analyzed markers in canine 
and human testicular tumors was similar. E.g. there was no immunoexpression of inhibin-a in 75% of canine 
and 100% of human cases of seminoma. The immunoreactivity of Ki-67 was intense in 40% of canine and 60% 
of human seminomas. Immunoexpression of inhibin-a in Leydig cell tumor was intense in 70% of canine and 
100% of human cases, respectively. Also the immunoreactivity of calretinin was intense in 75% of cases of 
canine and 100% of human Leydig cell tumors. In 50% of canine and 40% of human Leydig cell tumors, the 
immunoexpression of Ki-67 was weak.
Conclusions. The applied anti-human monoclonal antibodies against common antigens and markers of human 
testicular neoplasms could be routinely used for the immunohistochemical evaluation of canine testicular tumors. 
(Folia Histochemica et Cytobiologica 2014, Vol. 52, No. 4, 326–334)
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Introduction
Seminomas, Leydig cell tumors and Sertoli cell tumors 
represent the most frequent types of canine testicular 
neoplasms [1–4]. Although these tumors are also dia-
gnosed in humans, their incidence is markedly lower 
than in dogs. Both Leydig cell tumors and Sertoli cell 
tumors are well differentiated neoplasms originating 
from sex cords and gonadal stroma. Seminoma is a germ 
cell neoplasm with relatively homogenous microscopic 
structure, derived from carcinoma in situ of germinal 
epithelium. According to Looijeng et al. and Bush et 
al., most canine seminomas show histological structure 
resembling that of spermatocytic seminomas diagnosed 
in males (humans), and the classic form of seminoma is 
very rarely found in dogs [5, 6]. The recently observed 
continuous increase in the incidence of canine testicular 
tumors prompted us to perform immunohistochemical 
(IHC) analysis of these neoplasms with such markers 
as E-cadherin, inhibin-a, calretinin and Ki-67, and to 
comparative analysis of expressions of these proteins in 
canine and male testicular tumors. The use of the abo-
vementioned markers may provide detailed information 
on a character of testicular tumors. The expression of 
E-cadherin, involved in cell-cell adhesion, may provi-
de data on a metastatic potential of a tumor, and the 
expression of inhibin-a, a growth inhibitor, may reflect 
the rate of tumor growth. This information, combined 
with the data on the expression of Ki-67, a cellular pro-
liferation marker, can be helpful in establishing progno-
sis in dogs with testicular neoplasms. Also expression 
of calretinin, potential marker of secretory activity of a 
tumor, may be particularly useful in the case of testicu-
lar neoplasms. Furthermore, it should be emphasized 
that IHC analyses may frequently constitute a vital 
component of diagnostic process in both humans and 
dogs with mixed tumors or neoplasms presenting atypi-
cal histological structure. To the best of our knowledge, 
the expressions of markers from the abovementioned 
panel have not been comparatively analyzed in canine 
and male testicular tumors to date. Due to similarities 
in histological structure of male and canine testicular 
tumors and exposure of humans and dogs to similar 
environmental factors, testicular neoplasms seem to be 
a useful research model, enabling comparative analysis 
of carcinogenesis in these two species.
Material and methods
The study included specimens of canine (seminomas, Ley-
dig cell tumors and Sertoli cell tumors, 40 each) and male 
testicular tumors (15 seminomas and 5 Leydig cell tumors). 
We did not analyze male Sertoli cell tumors, as this type of 
malignancy is only sporadically diagnosed in humans [7].
Canine testicular tumors were obtained during surgery or 
postmortem examination, from dogs of various breeds and 
ages. The specimens of male neoplasms were obtained from 
archival collection of Hist-Med s.c. N.Z. M. Kosinski P. Prajs 
Histopathology Unit (Wroclaw, Poland). All the diagnoses 
were verified histopathologically according to the respective 
WHO guidelines [8].
The specimens of canine testicular tumors were fixed in 
7% buffered formalin (Chempur, Piekary Slaskie, Poland) 
for 24 h, embedded in paraffin and cut into 4 µm-thick 
sections. Histopathological evaluation of hematoxylin 
(Sigma-Aldrich, Saint Louis, MO, USA) and eosin (Chem-
pur) stained microscopic slides was based on the WHO 
classification of testicular tumors [8].
The IHC analyses were conducted on 4 µm-thick pa-
raffin sections mounted on glass slides (Dako, Glostrup, 
Denmark), deparaffinized in xylene (Stanlab, Lublin, Po-
land) and re-hydrated in alcohol gradients. The slides were 
heated on water bath (96°C, 20 min) with respective retrieval 
solutions, EnVision™ FLEX Target Retrieval Solution, 
High pH (Dako) for calretinin, E-cadherin and inhibin-a, 
or EnVision™ FLEX Target Retrieval Solution, Low pH 
(Dako) for Ki-67, to retrieve the antigens. The activity of 
endogenous peroxidase was blocked by 10 min treatment 
with EnVision™ FLEX Peroxidase-Blocking Reagent 
(Dako). Then respective primary antibodies: monoclonal 
mouse anti-human calretinin (clone DAK-Calret 1, 1:100, 
Dako), monoclonal mouse anti-human E-Cadherin (clone 
NCH-38, 1:50, Dako), monoclonal mouse anti-human 
inhibin-a (clone R1, 1:100, Dako) and monoclonal mouse 
anti-human Ki-67 antigen (clone MIB-1, 1:100, Dako) were 
applied, and the slides were incubated at room tempera-
ture for 20 min. Subsequently, the slides were washed in 
EnVision™ FLEX Wash Buffer (Dako), the reagents of 
EnVision™ FLEX/HR SM802 (Dako) visualization system 
were applied and slides were incubated at room tempe-
rature for 20 min. The IHC reactions were developed 
with 3,3-diaminobenzidine tetrahydrochloride (DAB), 
EnVision™ FLEX DAB+ Chromogen (Dako). Finally, 
the slides were rinsed in distilled water, counterstained 
with hematoxylin, dehydrated in alcohol gradients, passed 
through xylene and sealed.
The slides were subjected to computer-aided image 
analysis with a computer connected to Olympus BX53 
optic microscope (Olympus, Tokyo, Japan) equipped with 
Olympus Color View IIIa digital camera (Olympus). All 
the measurements were carried out with the aid of cell^A 
software (Olympus).
The immunoexpression of E-cadherin, inhibin-a, and 
calretinin was scored according to the modified semi-quan - 
titative IRS scale proposed by Remmele [9, 10]. The me-
thod takes into account both the proportion of positively 
stained cells and the intensity of the color reaction. The 
score constitutes the product of multiplication of both pa-
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rameters and ranges from 0 to 12 points [no reaction = 0 
points (–); weak reaction = 1–2 points (+), moderate re-
action = 3–5 points (++), intense reaction = 6–12 points 
(+++)]. Expression of Ki-67 was evaluated quantitatively, 
based on the percentage of positively-stained cells [0–5% = 
no reaction (–), 6–25% = weak reaction (+), 26–50% = 
moderate reaction (++), above 50% = intense reaction 
(+++)]. Evaluation of the expression of the markers was 
performed by three observers with relevant experience in 
analyzing immunohistochemical reactions.
The results were subjected to statistical analysis with 
Statistica PL package (StatSoft, Krakow, Poland). The non
-parametric Mann-Whitney U-test was used for intergroup 
comparisons of expression intensity. The threshold of stati-
stical significance of the test was set at p = 0.05.
Results
Immunoexpression of the studied antigens  
in canine and human seminomas
The immunohistochemical analysis of testicular semi-
nomas demonstrated clear species differences in the 
expression of the studied proteins. In 10% of canine 
testicular tumors inhibin-a expression was found to 
represent intense reaction, in 5% moderate reaction 
and in 10% weak reaction. In 75% of the studied cases 
no expression of the antigen could be demonstrated. 
In human testicular seminomas no immunoexpression 
of the inhibin-a antigen could be noted.
In the case of calretinin, in 50% of canine semi-
nomas intense reaction, in 15% moderate reaction 
and in 5% weak reaction was detected. 30% of se-
minomas manifested no immunoexpression of the 
protein. In humans none of the seminomas studied 
manifested the expression. 
The immunoexpression of E-cadherin in canine 
seminomas manifested intense reaction in 5% ca-
ses, moderate in 20% cases and weak in 25% cases. 
50% of studied tumors manifested no expression 
of the marker. In humans intense immunoreactivity 
of E-cadherin in seminomas was observed in 20% 
tumors, moderate in 40% tumors while in 40% of 
male tumors no expression of E-cadherin could be 
demonstrated. 
The immunoexpression of the Ki-67 antigen in 
40% of canine seminomas represented intense, in 
20% moderate and in 25% weak reaction. In 15% of 
tumors no expression of the Ki-67 antigen could be 
detected. In human seminomas intense immunoreac-
tivity of the Ki-67 antigen was found in 60% of cases 
and a moderate reaction manifested in 40% (Figure 1).
Statistical analysis of the results using Mann-Whit-
ney’s test demonstrated no significant differences 
(p > 0.05) in the expressions of Ki-67, inhibin-a and 
E-cadhedrin and a significant difference (p < 0.05) 
in the expression of calretinin in the seminomas of 
dogs and men.
Immunoexpression of the studied antigens  
in canine and human Leydig cell tumors
Tumors of Leydig cells, similarly to seminoma, ma-
nifested expression of studied proteins at variable 
levels. 
In canine tumors inhibin-a manifested intense 
reaction in 70% cases while no such expression 
could be detected in 30% cases. All the studied 
human Leydig cell tumors men showed the intense 
immunoreactivity of inhibin-a. 
Intense reaction of calretinin was detected in 
75% cases of canine Leydig cell tumors. However, 
25% of examined tumors showed no expression of 
calretinin. In men intense reaction of calretinin was 
disclosed in all examined Leydig cell tumors.
In canine Leydig cell tumors intense reaction of 
E-cadherin was detected in 40% cases, moderate 
in 30% and weak in 10% cases. 20% of the canine 
cases manifested no expression of E-cadherin. No 
expression of E-cadherin was detected in the exa-
mined human tumors. 
The expression of Ki-67 in canine Leydigomas 
was detected in 60% of cases and evaluated as 
a moderate reaction in 10% and in as a weak one 
— in 50% of the tumors; 40% of the examined 
tumors manifested no expression of the antigen. In 
human Leydig cell tumors the expression of Ki-67 
was weak and detected in 40% of cases while 60% 
of the tumors manifested no expression of the Ki-67 
antigen (Figure 2).
Statistical analysis of the results using Mann-Whit-
ney’s test demonstrated no significant differences 
(p > 0.05) in the expressions of Ki-67, calretinin 
and inhibin-a between canine and human Leydig 
cell tumors, however, a significant difference be-
tween both species was found in the expression of 
E-cadherin.
Immunoexpression of the studied antigens  
in canine Sertoli cell tumors
Neoplastic lesions originating from the supporting 
Sertoli cells were subjected to immunohistochemical 
analysis only in canine testes. In 30% of the tumors 
immunoreactivity of inhibin-a was evaluated as 
intense, in 25% of them as moderate and in 20% as 
weak reaction. In 25% of the cases no expression of 
the protein was detected. 
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The immunoreactivity of calretinin in 25% of 
cases of Sertoli cell tumors was intense, in 15% — 
moderate and in 10% — weak. In the entire material 
50% of the tumors manifested no expression of 
calretinin. 
In the case of E-cadherin moderate reaction was 
demonstrated in 20% of cases and the weak one 
in 15% cases. In 65% cases no expression of the 
antigen was detected. 
The immunoreactivity of proliferative antigen 
Ki-67 was intense in 20% of Sertoli cell tumors, in 
15% — moderate, and in 20% — weak. In 45% of 
the cases no expression of the protein was detected 
(Figure 3).
To compare the immunoreactivity of all studied 
antigens in both human and canine testicular tumors 
the data were summarized up and presented in 
a graph form in Figure 4.
Figure 1. Presence of the studied markers in dog seminoma: (A–D — dog; E, F — man). A. Cytoplasmic expression of 
inhibin-a (× 400); B. Cytoplasmic and nuclear (in individual cells) expressions of calretinin (× 400); C. Weak cytoplasmic 
expression of E-cadherin and strong membrane expression of this protein (× 400); D. Nuclear expression of Ki-67 antigen 
(× 400); E. Expression of E-cadherin in seminoma (× 400); F. Nuclear expression of Ki-67 in seminoma cells (× 400)
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Discussion
Our study was prompted by constant increase in the 
incidence of canine testicular tumors and resultant 
growing number of cases whose appropriate iden-
tification raises some controversies and requires 
additional IHC evaluation [4, 11, 12]. Moreover, we 
searched for biological characteristics which would be 
Figure 2. Presence of the studied markers in Leydig cell tumor: (A–D — dog; E–G — man). A. Strong cytoplasmic expres-
sion of inhibin-a (× 200); B. Cytoplasmic and nuclear expression of calretinin (× 400); C. Membranous expression of 
E-cadherin (× 400); D. Nuclear expression of Ki-67 (× 400); E. Inhibin-a in the cytoplasm of Leydig cell tumor (× 200); 
F. Strong cytoplasmic and nuclear expression of calretinin (× 400); G. Nuclear expression of Ki-67 (× 400)
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Figure 4. The summary of the assessment of immunoreactivity of all analyzed markers in canine and male testicular 
tumors. Y axis: the percentage of cells with the described intensity of immunoreactivity which was measured semi-quanti-
tatively as described in Methods
Figure 3. Presence of the studied markers in canine Sertoli cell tumors. A. Expression of inhibin-a in the cytoplasm  
(× 400); B. Cytoplasmic and nuclear expression of calretinin (× 400); C. Membrane expression of E-cadherin (× 600);  
D. Nuclear expression of Ki-67 (× 400)
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helpful in the optimization of the therapy of canine 
testicular tumors.
We analyzed the expression of a growth inhibitor, 
inhibin-a [13], as a marker of tumor growth poten-
tial. Inhibin-a is a polypeptide gonadal hormone, for 
the first time isolated from follicular fluid of cattle 
and pigs in 1985 [14–16]. It is responsible for the 
selective inhibition of FSH secretion [17]. Inhibin-a 
is composed of two subunits, a and b; the latter one 
comprises two subunits, A and B [18]. As inhibin-a is 
synthesized by Sertoli and Leydig cells, these two cel-
lular types show its strong cytoplasmic expression on 
IHC examination [14, 19–22]. We documented strong 
cytoplasmic expression of inhibin-a in canine testicu-
lar neoplasms, too; it was the strongest in Leydig cell 
tumors and somehow weaker in Sertoli cell tumors. 
This observation is consistent with previous reports 
on the expression of this protein in canine [17, 21] 
and male testicular tumors [23]. The fact that we 
observed the cytoplasmic expression of inhibin-a also 
in a small fraction of canine seminomas, may point 
to some differences in the biology of the latter tumor 
type in dogs and humans.
Calretinin is a neuronal calcium-binding protein 
which belongs to the calmodulin superfamily and acts 
as an intracellular regulator of Ca2+ concentration 
[24–26]. The extraneuronal expression of calretinin 
can be observed in both normal and neoplastic epithe-
lial cells of the ovaries, uterus, testes, thymus and ad-
renal glands [27]. Previous studies documented both 
cytoplasmic and nuclear expression of this protein; 
however, the exact mechanism and role of the extra-
neuronal expression of calretinin are still not fully un-
derstood [27]. As strong expression of calretinin was 
observed in cells involved in the synthesis of steroid 
hormones, this protein was postulated to be a marker 
of secretory activity of ovarian or testicular tumors [27, 
28]. In our study, the immunoreactivity of calretinin 
was the strongest in the case of canine and male 
Leydig cell tumors, i.e. in neoplasms with potential 
hormonal activity. The canine and human specimens 
did not differ significantly in terms of the calreti-
nin expression intensity. Also Radi and Miller [27] 
documented expression of calretinin in all types of ca-
nine testicular tumors; in contrast, Leydig cell tumors 
are the only testicular neoplasms showing expression 
of this protein in humans [29].
E-cadherin, a protein involved in cell-cell adhe-
sion, and thus associated with metastatic potential 
of neoplastic tumors [30, 31] is a transmembrane 
calcium-dependent protein of the cadherin family, to-
gether with often studied N- and P-cadherins [32, 33]. 
E-cadherins form complexes on the cytoplasmic side 
of the plasma membrane with another group of pro-
teins, catenins. Impaired formation of the cadherin-
catenin complexes is reflected by decreased intercel-
lular adhesion and results in increased invasive and 
metastatic potential of a tumor [32–36]. We observed 
strong membrane expression and weaker cytoplasmic 
expression of E-cadherin in canine testicular tumors. 
Most of the canine and male neoplasms analyzed 
in our study showed similar intensity of E-cadherin 
expression. The only exception pertained to Leydig 
cell tumors, in which the expression of E-cadherin was 
stronger, corresponding to 6–12 points of the Rem-
mele scale. It has been assumed that lower expression 
of E-cadherin is associated with greater mobility of 
cancer cells, which is reflected by the increased risk 
of tumor spread [32].
The nuclear expression of Ki-67 antigen serves as 
a basis for mitotic index determination, thus being a 
marker of tumor cells’ proliferation [37–39]. Ki-67 
belongs to the group of non-histone nuclear prote-
ins [40, 41]. The expression of this protein can be 
observed already during G1 phase of the cell cycle; it 
increases markedly during S and G2 phases, reaches 
its peak level during M phase, and is absent in G0 
cells. Consequently, Ki-67 is detected mostly in pro-
liferating cells [41, 42]. Determination of the mitotic 
index with an aid of anti-Ki-67 antibody constitutes 
an indirect method for measuring tumor aggressive-
ness. Both canine and male seminomas showed the 
strongest expression of Ki-67 in all testicular tumors 
analyzed in our study, however, with only slightly 
weaker immunoreactivity in Leydig cell tumors. Also 
Papaioannou et al. showed that the nuclear expression 
of Ki-67 is the strongest in seminomas, and somehow 
weaker in other types of canine testicular tumors [43]. 
The usefulness of Ki-67 antigen as a marker of cell 
proliferation was also confirmed in human testicular 
germ cell tumors [44].
Our study revealed that, apart from E-cadherin 
in Leydig cell tumors, the immunoreactivity of all 
the analyzed markers in canine and male testicular 
tumors was similar. This suggests that the antibodies 
tested in our study could be routinely used in IHC eva-
luation of canine testicular tumors. The appropriate 
interpretation of the expression of hereby examined 
proteins may be helpful in the selection of optimized 
treatment and establishing a prognosis in dogs with 
testicular neoplasms.
Moreover, the hereby documented analogies 
in the expression patterns of the selected markers/ 
/antigens suggest that canine tumors may present 
a useful model for the studies of carcinogenesis in 
human testes.
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